KR20160025734A - method for absorbing carbon dioxide into skin mucous membrane - Google Patents

method for absorbing carbon dioxide into skin mucous membrane Download PDF

Info

Publication number
KR20160025734A
KR20160025734A KR1020140112933A KR20140112933A KR20160025734A KR 20160025734 A KR20160025734 A KR 20160025734A KR 1020140112933 A KR1020140112933 A KR 1020140112933A KR 20140112933 A KR20140112933 A KR 20140112933A KR 20160025734 A KR20160025734 A KR 20160025734A
Authority
KR
South Korea
Prior art keywords
carbon dioxide
skin
organic acid
biofilm
water
Prior art date
Application number
KR1020140112933A
Other languages
Korean (ko)
Inventor
김창훈
Original Assignee
김창훈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김창훈 filed Critical 김창훈
Priority to KR1020140112933A priority Critical patent/KR20160025734A/en
Publication of KR20160025734A publication Critical patent/KR20160025734A/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00—Bathing devices for special therapeutic or hygienic purposes
    • A61H33/02—Bathing devices for use with gas-containing liquid, or liquid in which gas is led or generated, e.g. carbon dioxide baths
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0225—Carbon oxides, e.g. Carbon dioxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/04—Skin

Abstract

The present invention relates to a method for injecting carbon dioxide into the mucous membrane of skin, including: a first step (S10) for spraying, in a mist form, an aqueous solution in which sodium hydrogen carbonate is dissolved; a second step (S20) for coating an external use gel obtained by dissolving water-soluble chitosan in an organic acid including citric acid; a third step (S30) for forming a biofilm by making the water-soluble chitosan combined with the organic acid be in contact with the skin; and a fourth step (S40) for collecting the carbon dioxide generated from reaction between the sodium hydrogen carbonate and the organic acid in order to prevent the carbon dioxide from leaking through the biofilm, thereby making the carbon dioxide be absorbed into the mucous membrane. For the same, the present invention is capable of forming a biofilm generated by the dissolution of water-soluble chitosan into the organic acid including citric acid, and blocking the leakage of carbon dioxide generated by the reaction between the sodium hydrogen carbonate and the organic acid by using the biofilm. Therefore, the vast amount of carbon dioxide can be absorbed into the skin of the user.

Description

이산화탄소 경피 점막 흡수방법{method for absorbing carbon dioxide into skin mucous membrane}METHOD FOR ABSORBING CARBON DIOXIDE MUCOSAL MEMBRANE

본 발명은 이산화탄소 경피 점막 흡수방법에 관한 것으로, 보다 구체적으로는 구연산을 포함한 유기산에 의해 수용성 키토산이 용해되어 발생되는 바이오막을 형성하고, 형성된 바이오막이 탄산수소나트륨과 유기산이 반응하여 발생된 이산화탄소의 유출을 차단하여 사용자의 피부에 다량의 이상화탄소가 흡수될 수 있도록 하는 이산화탄소 경피 점막 흡수방법에 관한 것이다.The present invention relates to a method for absorbing carbon dioxide percutaneous mucous membrane, and more particularly, to a method for absorbing carbon dioxide percutaneous mucous membrane, which comprises forming a biomembrane formed by dissolving water-soluble chitosan by organic acid containing citric acid, To thereby absorb a large amount of abnormal carbon dioxide in the skin of the user.

통상적으로, 기포형상의 이산화탄소를 발생하여 경피 점막에 흡수 시키는 각종 미용 및 의료 효과를 얻기 위하여 많이 사용되고, 있다. 이러한, 이산화탄소 경피·경점막 흡수용 조성물은 무좀, 벌레 물림, 아토피성 피부염, 근육통, 관절통, 요통증, 신경염, 건선, 티눈, 굳은살, 어린선, 수장족저 각화증, 각종 화농성 피부 질환, 주근께, 피부 거칠어짐, 거무칙칙한 피부, 피부 윤기의 쇠퇴, 머리카락 윤기의 쇠퇴 등의 피부나 모발 관리 등에 이용하고 있다.It is commonly used to obtain various cosmetic and medical effects of generating bubble-shaped carbon dioxide and absorbing it into the transdermal mucosa. The compositions for absorbing carbon dioxide percutaneous and intraluminal mucous membranes can be used for the treatment and prophylaxis of athlete's foot, insect bites, atopic dermatitis, muscular pain, arthralgia, urinary pain, neuritis, psoriasis, corn, hard flesh, Skin roughness, dull and dull skin, decline of skin gloss, decline of hair gloss, and the like.

일예로, 일본국 특허공개‘2000-319187호’공보에 개시되어 있다. 하지만, 이 조성물은 이산화탄소를 기포형상으로 유지하지 못하여 미용 혹은 의료 효과를 얻는 데 필요한 양의 이산화탄소를 유지하기 어려워 미용 혹은 의료 효과를 얻을 수 없었다.For example, Japanese Patent Application Laid-Open No. 2000-319187 discloses a method of manufacturing a semiconductor device. However, since this composition can not maintain the carbon dioxide in a bubble form, it is difficult to maintain a sufficient amount of carbon dioxide necessary for obtaining a cosmetic or medical effect, and thus the cosmetic or medical effect can not be obtained.

일본국 특허공개 2000-319187호 “二酸化炭素皮粘膜吸用組成物”Japanese Patent Application Laid-Open No. 2000-319187 " Composition for absorbing carbon dioxide dermal mucosa "

이에 따라 본 발명은 상기와 같은 종래의 문제점을 근본적으로 해결하기 위한 것으로서, 구연산을 포함한 유기산에 의해 수용성 키토산이 용해되어 발생되는 바이오막을 형성하고, 형성된 바이오막이 탄산수소나트륨과 유기산이 반응하여 발생된 이산화탄소의 유출을 차단하여 사용자의 피부에 다량의 이상화탄소가 흡수될 수 있도록 하는 이산화탄소를 경피 점막을 통해 흡수시키는 방법을 제공하려는데 그 목적이 있다.SUMMARY OF THE INVENTION Accordingly, the present invention has been made to solve the above-mentioned conventional problems, and it is an object of the present invention to provide a biomembrane which is formed by dissolving water-soluble chitosan by organic acid including citric acid, And to provide a method of absorbing carbon dioxide through the transcutaneous mucosa to prevent the outflow of carbon dioxide and to absorb a large amount of abnormal carbon dioxide on the user's skin.

이러한 목적을 달성하기 위해 본 발명은 이산화탄소를 피부 점막에 흡수시키는 방법에 있어서: 탄산수소나트륨이 용해된 수용액 미스트를 사용자의 피부에 분사하는 제1단계; 상기 제1단계의 피부에 구연산을 포함한 유기산에 수용성 키토산이 용해된 외용 젤을 도포하는 제2단계; 상기 제2단계의 수용성 키토산이 유기산과 함께 혼합된 상태로 피부와 접촉하여 바이오막을 형성하는 제3단계; 및 상기 제1단계의 탄산수소나트륨과 유기산이 반응하여 발생된 이산화탄소를 바이오막을 통해 외부로 유출되지 않도록 포집하여 경피 점막 흡수하는 제4단계;를 포함하여 이루어진 것을 특징으로 한다.In order to achieve the above object, the present invention provides a method of absorbing carbon dioxide into a skin mucosa, comprising: a first step of spraying an aqueous solution mist containing dissolved sodium bicarbonate onto a skin of a user; A second step of applying a topical gel containing water-soluble chitosan dissolved in an organic acid containing citric acid to the skin of the first step; A third step of contacting the water-soluble chitosan of the second step with the organic acid to form a biofilm in contact with the skin; And a fourth step of capturing the carbon dioxide generated by the reaction of the sodium bicarbonate of the first step with the organic acid and the percutaneous mucous membrane by collecting the generated carbon dioxide so that the carbon dioxide does not flow out to the outside through the bio membrane.

한편, 이에 앞서 본 명세서 및 특허청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서 본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 가장 바람직한 일 실시예에 불과할 뿐이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있음을 이해하여야 한다.It should be understood, however, that the terminology or words of the present specification and claims should not be construed in an ordinary sense or in a dictionary, and that the inventors shall not be limited to the concept of a term It should be construed in accordance with the meaning and concept consistent with the technical idea of the present invention based on the principle that it can be properly defined. Therefore, the embodiments described in the present specification and the configurations shown in the drawings are merely the most preferred embodiments of the present invention, and not all of the technical ideas of the present invention are described. Therefore, It is to be understood that equivalents and modifications are possible.

이상의 구성 및 작용에서 설명한 바와 같이, 본 발명은 구연산을 포함한 유기산에 의해 수용성 키토산이 용해되어 발생되는 바이오막을 형성하고, 형성된 바이오막이 탄산수소나트륨과 유기산이 반응하여 발생된 이산화탄소의 유출을 차단하여 사용자의 피부에 다량의 이상화탄소가 흡수되는 효과를 제공한다.As described above, the present invention provides a biomembrane which is formed by dissolving water-soluble chitosan by organic acid including citric acid, and the formed biomembrane prevents the outflow of carbon dioxide generated by the reaction of sodium bicarbonate and organic acid, A large amount of ideal carbon dioxide is absorbed into the skin of the user.

도 1은 본 발명에 따른 이산화탄소 경피 점막 흡수방법을 순차적으로 나타내는 블록도.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a block diagram sequentially showing a method for absorbing a carbon dioxide percutaneous mucous membrane according to the present invention. FIG.

이하, 첨부된 도면을 참조하여 본 발명에 따른 바람직한 실시예를 상세하게 설명한다.Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.

도 1은 본 발명에 따른 이산화탄소 경피 점막 흡수방법을 순차적으로 나타내는 블록도이다.1 is a block diagram sequentially showing a method of absorbing a carbon dioxide percutaneous mucous membrane according to the present invention.

본 발명은 이산화탄소 경피 점막 흡수방법에 관련되며, 제1단계(S10), 제2단계(S20), 제3단계(S30), 제4단계(S40)를 주요 구성으로 한다.The present invention relates to a carbon dioxide transcutaneous mucous membrane absorption method, and comprises a first step (S10), a second step (S20), a third step (S30), and a fourth step (S40).

본 발명에 따른 제1단계(S10)는 탄산수소나트륨(sodium hydrogen carbonate)이 용해된 수용액 미스트를 사용자의 피부에 분사한다. 제1단계(S10)는 탄산수소나트륨을 용해하여 수용된 수용액을 미스트에 담아 사용자의 피부에 분사하게 된다. 이러한, 제1단계(S10)의 탄산수소나트륨은 일명 ‘베이킹소다’라고도 부르는 것으로 약염기성으로 상온에서 고체로 존재한다. 이러한, 탄산수소나트륨은 용해되는 것은 약 20℃부터 이산화탄소를 발생하면서 분해되는 것으로 인체에 전혀 무해하고 알레르기반응을 일으키지 않는 성분으로 피부에 효율적인 효과를 제공하는 것으로 지친 피부에 활력을 불어넣어주고 피부에 축적된 나쁜 성분, 땀, 기름기 등의 오염물질을 깨끗하게 씻어낼 수 있도록 한다. 그리고, 탄산수소나트륨을 용해한 상태로 미스트 사용하는 것은 피부 전체에 가장 빠르면서 골고루 분사할 수 있도록 하는 것이다.In the first step S10 according to the present invention, an aqueous solution mist in which sodium hydrogen carbonate is dissolved is sprayed onto the user's skin. In the first step S10, sodium bicarbonate is dissolved, and the aqueous solution contained in the mist is sprayed onto the user's skin. The sodium hydrogencarbonate in the first step S10 is also referred to as " baking soda ", and is weakly basic and exists as a solid at room temperature. Such sodium bicarbonate dissolves when it is decomposed while generating carbon dioxide from about 20 ° C. It is harmless to the human body and does not cause allergic reaction. It provides effective effect to the skin. It gives vitality to tired skin, It is able to wash away accumulated bad ingredients, sweat, grease and other contaminants cleanly. The use of mist in the state of dissolving sodium hydrogencarbonate makes it possible to spray evenly and uniformly throughout the skin.

또, 본 발명에 따른 제2단계(S20)는 상기 제1단계(S10)의 피부에 구연산을 포함한 유기산에 수용성 키토산이 용해된 외용 젤을 도포한다. 상술한 제1단계(S1)에서 탄산수소나트륨이 용해된 수용액 미스트를 사용자의 피부에 분사한 다음, 구연산이 포함된 유기산 상에 키토산이 수용된 상태로 용해하여 완성된 외용 젤을 사용자의 피부에 재차 도포하게 된다.The second step (S20) according to the present invention is to apply a topical gel in which water-soluble chitosan is dissolved in an organic acid containing citric acid to the skin of the first step (S10). In the first step S1, the aqueous solution of sodium bicarbonate dissolved in water is sprayed onto the user's skin, and the external gel is dissolved in the state that the chitosan is contained in the organic acid containing citric acid. Respectively.

또, 본 발명에 따른 제3단계(S30)는 상기 제2단계(S20)의 수용성 키토산이 피부와 접촉하여 바이오막을 형성한다. 제3단계(S30)는 상술한 제1단계(S10)에 탄산수소나트륨이 용해된 수용액 미스트를 사용자의 피부에 분사한 것과 제2단계(S20)에서 구연산이 포함된 유기산에 키토산이 함께 수용되어 혼합될 때, 바이오막을 형성하게 된다.In the third step S30 according to the present invention, the water-soluble chitosan in the second step S20 is brought into contact with the skin to form a biomembrane. The third step S30 is a step of spraying the user's skin with the aqueous solution of the aqueous solution of sodium hydrogen carbonate dissolved in the first step S10 and chitosan in the organic acid containing citric acid together in the second step S20 When mixed, they form a biomembrane.

또, 본 발명에 따른 제4단계(S40)는 상기 제1단계(S10)의 탄산수소나트륨과 유기산이 반응하여 발생된 이산화탄소를 바이오막을 통해 외부로 유출되지 않도록 포집하여 경피 점막 흡수한다. 제4단계(S40)는 상술한 제1단계(S10)에서 탄산수소나트륨이 용해된 수용액과 상술한 제1단계(S10)의 피부에 구연산을 포함한 유기산에 수용성 키토산이 용해된 외용 젤이 혼합되어 서로의 반응을 통해 이산화탄소가 발생하게 된다. 이렇게 반응된 이산화탄소는 상술한 제3단계(S30)에 수용성 키토산이 피부와 접촉하여 바이오막을 통해 상기 이산화탄소의 대기로 발산이 억제하여 피부에 흡수될 수 있도록 한다.In a fourth step S40 according to the present invention, the carbon dioxide produced by the reaction of the sodium bicarbonate and the organic acid in the first step S10 is absorbed through the biofilm so as not to be leaked to the outside, and absorbed through the transdermal mucosa. In the fourth step S40, an aqueous solution in which sodium bicarbonate is dissolved in the first step S10 is mixed with an external gel in which water-soluble chitosan is dissolved in an organic acid containing citric acid in the skin of the first step S10 described above Carbon dioxide is generated through the reaction of each other. In the third step S30, the water-soluble chitosan is allowed to contact with the skin to inhibit divergence of the carbon dioxide into the atmosphere through the biomembrane to be absorbed into the skin.

도 1을 참조하여 본 발명의 사용에 있어서, 먼저 사용자의 피부에 탄산수소나트륨이 용해된 수용액 미스트를 분사한 다음, 구연산을 포함한 유기산에 수용성 키토산이 용해된 외용 젤을 재차 사용자의 피부에 도포한다. 이때, 수용성 키토산이 탄산수소나트륨이 용해된 수용액과 서로 혼합되어 바이오막이 형성되고, 탄산수소나트륨이 용해된 수용액과 구연산을 포함한 유기산에 수용성 키토산이 용해된 외용 젤이 혼합되어 발생되는 이산화탄소가 상술한 바이오막을 통해 이산화탄소의 대기로 발산을 통해 공기중에 사라짐을 억제하여 장시간(약 24시간) 피부에 흡수될 수 있도록 한다.1, first, an aqueous solution of sodium bicarbonate dissolved in a user's skin is sprayed onto a skin of a user, and then an external gel in which water-soluble chitosan is dissolved in organic acid containing citric acid is applied to the user's skin again . At this time, the water-soluble chitosan is mixed with an aqueous solution in which sodium bicarbonate is dissolved to form a biomembrane. Carbon dioxide generated by mixing an aqueous solution in which sodium bicarbonate is dissolved and an external gel in which water-soluble chitosan is dissolved in an organic acid containing citric acid is mixed Through biomembrane, it dissipates to the atmosphere of carbon dioxide and suppresses disappearance into the air, so that it can be absorbed into the skin for a long time (about 24 hours).

이와 같이, 본 발명은 구연산을 포함한 유기산에 의해 수용성 키토산이 용해되어 발생되는 바이오막을 형성하고, 형성된 바이오막이 탄산수소나트륨과 유기산이 반응하여 발생된 이산화탄소의 유출을 차단하여 사용자의 피부에 다량의 이상화탄소가 흡수되는 효과를 제공한다.As described above, the present invention provides a biomembrane which is formed by dissolving water-soluble chitosan by organic acid including citric acid, and the formed biomembrane blocks the outflow of carbon dioxide generated by the reaction of sodium bicarbonate and organic acid, It provides carbon dioxide absorption effect.

본 발명은 기재된 실시예에 한정되는 것은 아니고, 본 발명의 사상 및 범위를 벗어나지 않고 다양하게 수정 및 변형할 수 있음은 이 기술의 분야에서 통상의 지식을 가진 자에게 자명하다. 따라서 그러한 변형예 또는 수정예들은 본 발명의 특허청구범위에 속한다 해야 할 것이다.It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit and scope of the invention as defined by the appended claims. It is therefore intended that such variations and modifications fall within the scope of the appended claims.

S10: 제1단계 S20: 제2단계
S30: 제3단계 S40: 제4단계S10: First step S20: Second step
S30: Third step S40: Fourth step

Claims (1)

이산화탄소를 피부 점막 흡수시키는 방법에 있어서:
탄산수소나트륨이 용해된 수용액 미스트를 사용자의 피부에 분사하는 제1단계(S10);
상기 제1단계(S10)의 피부에 구연산을 포함한 유기산에 수용성 키토산이 용해된 외용 젤을 도포하는 제2단계(S20);
상기 제2단계(S20)의 수용성 키토산이 유기산과 함께 혼합된 상태로 피부와 접촉하여 바이오막을 형성하는 제3단계(S30); 및
상기 제1단계(S10)의 탄산수소나트륨과 유기산이 반응하여 발생된 이산화탄소를 바이오막을 통해 외부로 유출되지 않도록 포집하여 경피 점막 흡수하는 제4단계(S40);를 포함하여 이루어진 것을 특징으로 하는 이산화탄소 경피 점막 흡수방법.A method for absorbing carbon dioxide into a skin mucosa membrane comprising:
A first step (S10) of spraying an aqueous solution mist in which sodium hydrogencarbonate is dissolved onto the skin of a user;
A second step (S20) of applying a topical gel in which water-soluble chitosan is dissolved in organic acid containing citric acid to the skin of the first step (S10);
A third step (S30) of contacting the water-soluble chitosan of the second step (S20) with the organic acid in contact with the skin to form a biofilm; And
And a fourth step (S40) of collecting the carbon dioxide generated by the reaction of sodium bicarbonate and organic acid in the first step (S10) so as not to flow out through the biofilm and absorbing the percutaneous mucous membrane. Transdermal mucosal absorption method.
KR1020140112933A 2014-08-28 2014-08-28 method for absorbing carbon dioxide into skin mucous membrane KR20160025734A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140112933A KR20160025734A (en) 2014-08-28 2014-08-28 method for absorbing carbon dioxide into skin mucous membrane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140112933A KR20160025734A (en) 2014-08-28 2014-08-28 method for absorbing carbon dioxide into skin mucous membrane

Publications (1)

Publication Number Publication Date
KR20160025734A true KR20160025734A (en) 2016-03-09

Family

ID=55536260

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140112933A KR20160025734A (en) 2014-08-28 2014-08-28 method for absorbing carbon dioxide into skin mucous membrane

Country Status (1)

Country Link
KR (1) KR20160025734A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000319187A (en) 1999-05-06 2000-11-21 Medion Research Laboratories Inc Carbon dioxide transcutaneous and transmucosal absorption composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000319187A (en) 1999-05-06 2000-11-21 Medion Research Laboratories Inc Carbon dioxide transcutaneous and transmucosal absorption composition

Similar Documents

Publication Publication Date Title
MX2017013983A (en) Use of active agents during chemical treatments.
EA201170876A1 (en) APPLICATION OF A COMPOSITION-APPROPRIATE COMPOSITION, IN SUBSTANCE, NOT CONTAINING PHARMACEUTICAL ACTIVE INGREDIENTS, FOR TREATING HUMAN SKIN
JP2012517420A5 (en)
PH12018550062A1 (en) Topical film-forming spray
MX344259B (en) Hair dyeing process using at least one ortho-diphenol, a manganese or zinc salt, hydrogen peroxide, (bi)carbonate, an alkaline agent and a titanium or scandium salt.
CL2010001620A1 (en) Agricultural, personal care, home care and coating composition comprising silicone and another additional component; aqueous and non-aqueous emulsion comprising the agricultural composition; and method for formulating said compositions (div. sol. no. 656-207).
MX2010004169A (en) Transdermal drug delivery using an osmolyte and vasoactive agent.
PE20121709A1 (en) A PHARMACEUTICAL COMPOSITION TO TREAT CANCER INCLUDING TRYPSINOGEN AND / OR CHEMOTRIPSINOGEN AND AN ACTIVE AGENT SELECTED FROM A SELENIUM COMPOUND, A VAINILLOID COMPOUND AND A CYTOPLASMIC GLYCOLYSIS REDUCING AGENT
NZ599265A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
RU2013132566A (en) THERAPEUTIC AGAINST HERNIASIS
MX2023007080A (en) Method for treating fibrosis.
EP3295932A3 (en) Stable odf composition containing hardly soluble therapeutic agent
IS7912A (en) Use of docosahexenoic acid as an active agent for the treatment of lipodystrophy
KR20160025734A (en) method for absorbing carbon dioxide into skin mucous membrane
EA202092077A1 (en) LOCAL COMPOSITIONS CONTAINING STRONZIUM AND METHYLSULPHONYLMETHANE (MSM) AND METHODS OF TREATMENT
WO2019099860A3 (en) Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing
CO2021010273A2 (en) A composition for the treatment of periodontitis and the regeneration of the interdental papilla
AR095020A1 (en) CONDOM
PE20220060A1 (en) AN APPARATUS AND METHODS FOR MEASURING, MONITORING AND CONTROLLING CHEMICAL CONCENTRATIONS OF ACTIVE INGREDIENTS IN TREATMENT SOLUTIONS OF VEGETABLES AND PLANTS
US8197856B2 (en) Kit for promoting hair growth
MX2016014261A (en) Use of 1,3-propanedisulfonic acid or pharmaceutically acceptable salts thereof for the treatment of sarcoidosis.
RU2288696C1 (en) Lotion-deodorant
US9949810B2 (en) Safe method for bleaching teeth
MX2021004937A (en) Bioenergetic nicotinic acid glycerol esters, compositions and methods of using same.
JP6837956B2 (en) Hydrogen generation sheet and its manufacturing method

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
J201 Request for trial against refusal decision